MexicoAustraliaFranceGreat BritianIrelandGermanyNetherlandsSouth Africa     FEEDBACK  |  CONTACT US

PROCYSBI™  (cysteamine bitartrate)

 

Delayed-Release capsules, is FDA approved for the management of nephropathic cystinosis in adults and children 6 years and older.

 

 

Learn more about PROCYSBI

 


       INTERNATIONAL REGISTRY

       

CYSTARAN™

Sigma-Tau Pharmaceuticals Launches Cystaran For The Treatment of Corneal Cystine Crystal Accumulation in Patients With Cystinosis 

Learn More about Cystaran


   QUICK RESOURCES

         What Is Cystinosis?

         Join Our Email List

          A Guide for Parents, Patients,
          and Healthcare Professionals: (5 MB PDF)
 
          English   Turkish   Persian
          Spanish   Arabic   Dutch
 


LEE KNAUS 

 

Cystinosis: an Artists Inspiration 

Read more about Lee Knaus

 

 
 

 

UCSD CYSTINOSIS STUDY

 

    The Pediatric Neurology Research Group at the University of California, San Diego (UCSD) is conducting a research study on "Outcome and Quality of Life in Adults with Cystinosis"

    The Study involves an online questionnaire, and is looking for two groups of participants.

 

More Information »

 

 



 

 
 
© 1998 - 2013 Cystinosis Foundation, Inc., 58 Miramonte Drive, Moraga, CA 94556
1-888-631-1588 or (925) 631-1588 info@cystinosis.com


Website Design Donated By ePaiges Design Group, LLC